Appointment of Chief Business Officer ...
18 November 2015 - 8:00AM
UK Regulatory
/**/
RNS Number : 0720G
Collagen Solutions PLC
18 November 2015
Collagen Solutions Plc
(the "Company" or the "Group")
Appointment of Chief Business
Officer
The Board of Collagen Solutions plc (AIM: COS),
the developer and manufacturer of medical grade collagen components
for use in regenerative medicine, medical devices and in-vitro diagnostics, announces the
appointment of Jamal Rushdy as Chief Business Officer with
immediate effect.
Mr Rushdy has over 20 years' experience in the
medical device arena, specifically within two mid-size high growth
public companies and three successful start-ups. He has a unique
track record of building businesses with successful exits and
transforming organisations through integration and performance
improvement, adding value through business development and
functional leadership.
Mr Rushdy has been employed at Tornier Inc, a
Minneapolis extremities and biologics company, since 2007, most
recently as Vice President of US Sales Operations. During his
tenure he also served as the Vice President of the company's Global
Sports Medicine, Biologics, and Business Development group where he
led multiple acquisitions and corporate partnerships, including
several focused on biologic technologies. Previous roles include
Vice President of Operations & Business Development at Nexa
Orthopedics in San Diego where he led his division through a
high-growth period driven by a significant expansion in the sales
force and rapid product introductions leading to the successful
acquisition of Nexa by
Tornier.
Mr Rushdy has a BSc in Mechanical Engineering
from the University of California, San Diego and an MBA from the
University of California Graduate School of Management in marketing
and finance.
Commenting on
the appointment, Stewart White, CEO of Collagen Solutions
said: "Jamal
will bring a wealth of sector specific business acumen and
creativity to Collagen Solutions. His experience in the industry is
second to none and we are delighted he will be joining us as at
this exciting time in our growth and will be charged with growing
our sales operations across the globe. We are at a key point in our
growth where increased business development is critical and Jamal
is well positioned to drive this forward. Our Chief Business
Officer prior to this appointment, Geoff Bennett will continue as an
Executive Director of Collagen Solutions plc and as Managing
Director and CEO of our wholly-owned subsidiary Southern Lights
Biomaterials, located in New Zealand. Mr Bennett will also
continue to lead our business development efforts in
Asia."
Enquiries:
Collagen Solutions Plc
|
|
David Evans, Chairman
|
Tel: 07740 084 452
|
Stewart White, CEO
|
Tel: 0141 648 9100
|
|
|
Panmure Gordon
|
|
Robert Naylor (Corporate Finance)
|
Tel: 020 7886 2500
|
|
|
|
|
Walbrook PR Ltd
|
Tel: 020 7933 8780 or collagen@walbrookpr.com
|
Anna Dunphy
|
Mob: 07876 741 001
|
Mike Wort
|
Mob: 07900 608 002
|
|
|
|
This information is provided by RNS
The company news service from the
London Stock Exchange
END
MSCFFUFUWFISEEF
Healthcare Inv (LSE:HIO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Healthcare Inv (LSE:HIO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Healthcare Inv (Londoner Börse): 0 Nachrichtenartikel
Weitere Healthcare Inv News-Artikel